95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008
HB0680

 

Introduced 2/6/2007, by Rep. Elaine Nekritz

 

SYNOPSIS AS INTRODUCED:
 
New Act

    Creates the Biomonitoring Safety Net Act. Requires the Department of Public Health, in collaboration with the Illinois Environmental Protection Agency, to establish an Environmental Contaminant Biomonitoring Program to monitor the presence and concentration of designated chemicals in the bodies of the people of this State. Requires the Department and Agency to establish a Scientific Guidance Panel to make recommendations regarding the design and implementation of the Program, including specific recommendations for chemicals that are priorities for biomonitoring, with members appointed by the Governor, the President of the Senate, and the Speaker of the House. Designates the criteria for determining priority chemicals for inclusion in the Program. Requires that biomonitoring findings be disseminated to the general public and the Department, in collaboration with the Agency, submit a report every 2 years to the General Assembly containing the findings of the Program.


LRB095 03973 KBJ 24006 b

FISCAL NOTE ACT MAY APPLY

 

 

A BILL FOR

 

HB0680 LRB095 03973 KBJ 24006 b

1     AN ACT concerning public health.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 1. Short title. This Act may be cited as the
5 Biomonitoring Safety Net Act.
 
6     Section 5. Findings and purposes.
7     (a) The General Assembly finds all of the following:
8         (1) An estimated 100,000 chemicals are registered for
9     use today in the United States. Another 2,000 chemicals are
10     added each year.
11         (2) Some toxicological screening data exists for only
12     7% to 10% of these chemicals. More than 90% of these
13     chemicals have never been tested for their effects on human
14     health. Large numbers of these chemicals are found in
15     cosmetics, personal care products, pesticides, food dyes,
16     cleaning products, fuels, and plastics.
17         (3) As a result, people are exposed to chemicals daily.
18     Many of these chemicals persist in the environment or
19     accumulate and remain in body fat and have been shown to be
20     toxic.
21         (4) The Centers for Disease Control and Prevention has
22     documented the presence of 148 environmental chemicals in
23     the blood and urine of Americans of all ages and races.

 

 

HB0680 - 2 - LRB095 03973 KBJ 24006 b

1     (b) The purposes of this Act are all of the following:
2         (1) To establish an Environmental Contaminant
3     Biomonitoring Program to monitor the presence and
4     concentration of designated chemicals in the bodies of the
5     people of this State.
6         (2) To produce biomonitoring studies that provide data
7     helping scientists, researchers, public health personnel,
8     and community members explore linkages between chemical
9     exposure and health concerns.
10         (3) To collect biomonitoring data that supports
11     Illinois public health by establishing trends in chemical
12     exposures, validating modeling and survey methods,
13     supporting epidemiological studies, identifying highly
14     exposed communities, addressing the data gaps between
15     chemical exposures and specific health outcomes, informing
16     health responses to unanticipated emergency exposures,
17     assessing the effectiveness of current regulations, and
18     setting priorities for reform.
 
19     Section 10. Definitions. As used in this Act:
20     "Agency" means the Illinois Environmental Protection
21 Agency.
22     "Department" means the Department of Public Health.
23     "Program" means the Environmental Contaminant
24 Biomonitoring Program.
 

 

 

HB0680 - 3 - LRB095 03973 KBJ 24006 b

1     Section 15. Environmental biomonitoring safety net. The
2 Department of Public Health, in collaboration with the Illinois
3 Environmental Protection Agency, shall establish an
4 Environmental Contaminant Biomonitoring Program to monitor the
5 presence and concentration of designated chemicals in the
6 bodies of the people of this State. The Program shall utilize
7 biological specimens, as appropriate, to identify designated
8 chemicals that are present in the bodies of the people of this
9 State. Biomonitoring shall take place on a strictly voluntary
10 and confidential basis. Results reported shall not disclose
11 individual confidential information of participants.
12 Appropriate biological specimens must be used to monitor and
13 assess the presence and concentration of designated chemicals.
14 Biological specimens shall be analyzed by laboratories
15 operated by the Department, the Agency, or their contractors.
16     All participants must be evaluated for the presence of
17 designated chemicals as a component of the biomonitoring
18 process. Individual participants may request and shall receive
19 their complete results. When either physiological or chemical
20 data obtained from a participant indicate a significant known
21 risk, Program staff experienced in communicating biomonitoring
22 results shall consult with the individual and recommend
23 follow-up steps as appropriate.
24     The Program shall incorporate, as appropriate, the methods
25 utilized by the Centers for Disease Control and Prevention for
26 the studies known collectively as the National Report on Human

 

 

HB0680 - 4 - LRB095 03973 KBJ 24006 b

1 Exposure to Environmental Chemicals. The Department, in
2 collaboration with the Program, shall conduct statistical and
3 epidemiological analyses of the biomonitoring results. No
4 governmental agency or private person or entity may
5 discriminate against a person or community based upon the
6 biomonitoring results.
 
7     Section 20. Scientific Guidance Panel. In implementing the
8 Program, the Department and the Agency shall establish a
9 Scientific Guidance Panel. The Panel shall be composed of 9
10 members, whose expertise shall encompass the disciplines of
11 public health, epidemiology, biostatistics, environmental
12 medicine, risk analysis, exposure assessment, developmental
13 biology, laboratory sciences, bioethics, maternal and child
14 health with a specialty in breastfeeding, and toxicology. The
15 Governor shall appoint 3 members to the Panel, the President of
16 the Senate shall appoint 3 members, and the Speaker of the
17 House shall appoint 3 members. Members shall be appointed for
18 3-year terms, except that, with respect to the initial
19 appointees, each appointing power shall appoint one member for
20 a one-year term and one member for a 2-year term. Members may
21 be reappointed for additional terms without limitation.
22 Members shall serve until their successors are appointed and
23 have qualified. Vacancies shall be filled in the same manner as
24 the original appointments, and any member so appointed shall
25 serve during the remainder of the term for which the vacancy

 

 

HB0680 - 5 - LRB095 03973 KBJ 24006 b

1 occurred. The Panel shall meet, at a minimum, 3 times per year.
2 The Agency shall be responsible for staffing and administration
3 of the Panel. Members of the Panel shall be reimbursed for
4 travel and other necessary expenses incurred in the performance
5 of their duties under this Act, but shall not receive a salary
6 or compensation.
7     The Panel shall provide scientific peer review and make
8 recommendations regarding the design and implementation of the
9 Program, including specific recommendations for chemicals that
10 are priorities for biomonitoring. The Panel shall retain final
11 decision-making authority. The Panel shall recommend priority
12 chemicals for inclusion in the Program using all of the
13 following criteria:
14         (1) The degree of potential exposure to the public or
15     specific subgroups, including, but not limited to, certain
16     occupations.
17         (2) The likelihood of a chemical being a carcinogen or
18     toxicant based on peer-reviewed health data, its chemical
19     structure, or the toxicology of chemically related
20     compounds.
21         (3) The limits of laboratory detection for the
22     chemical, including the ability to detect the chemical at
23     levels low enough to be expected in the general population.
24         (4) Any other criteria the Panel deems significant.
25     The Panel may recommend additional designated chemicals
26 not included in the National Report on Human Exposure to

 

 

HB0680 - 6 - LRB095 03973 KBJ 24006 b

1 Environmental Chemicals for inclusion in the Program using all
2 of the following criteria:
3         (A) Exposure or potential exposure to the public or
4     specific subgroups.
5         (B) The known or suspected health effects resulting
6     from some level of exposure based on peer-reviewed
7     scientific studies.
8         (C) The need to assess the efficacy of public health
9     actions to reduce exposure to a chemical.
 
10     Section 25. Dissemination of biomonitoring findings. The
11 Department and the Agency shall disseminate biomonitoring
12 findings to the general public via appropriate media, including
13 governmental and other Internet websites, in a manner that is
14 understandable to the average person.
 
15     Section 30. Program findings; report. Every 2 years,
16 beginning on the effective date of this Act, the Department, in
17 collaboration with the Agency, shall submit a report to the
18 General Assembly containing the findings of the Program and
19 shall include in the report additional activities and
20 recommendations to date. Copies of the report shall be made
21 available via appropriate media to the public.